Concordia Healthcare Corp. T.CXR.R

RE:RE:RE:$34 sucks

[Stockcoach1]

sunshine7 wrote:
agreed, financials in absence of conference call does not do it justice. This is the first full quarter of the new company and already they are adding products not previously announced. This not a company that is thinking short term. As MT says, take care of business and the share price will respond.

Sunshine, I loved the fact that Mark refused to provide the names of the meds CXR purchased and launched, citing competitive reasons. That may be true but it also shuts down shorts and the likes of Cohodes and FT. If they don't know the product's names they can't track any price increases or fabricate stories. In addition it leaves everyone (including the analysts) guessing, about how these products might contribute to the next quarter.
Brilliant